Amundi Pmv Pharmaceuticals, Inc. Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Amundi holds 26,182 shares of PMVP stock, worth $39,273. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,182

Holding current value

$39,273

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$1.44 - $1.69 $37,702 - $44,247	26,182 New	26,182 $39,000
Q4 2023 Feb 14, 2024	BUY	$1.23 - $6.6 $32,203 - $172,801	26,182 New	26,182 $81,000

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

Orbimed Advisors LLC San Diego, CA

6.48M
Shares

$9.71 Million
0.23% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

3.65M
Shares

$5.47 Million
0.08% of portfolio
Sio Capital Management, LLC New York, NY

3.21M
Shares

$4.82 Million
2.53% of portfolio
Euclidean Capital LLC New York, NY

2.63M
Shares

$3.94 Million
0.43% of portfolio
Alkeon Capital Management LLC New York, NY

2.34M
Shares

$3.52 Million
0.01% of portfolio

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $68.4M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account